ENSG:NGS-The Ensign Group Inc. (USD)

EQUITY | Medical Care Facilities | Nasdaq Global Select

Last Closing

USD 119.28

Change

+1.14 (+0.96)%

Market Cap

USD 1.10B

Volume

0.20M

Analyst Target

USD 62.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ensign Group Inc offers skilled nursing & rehabilitative care services in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas & Washington.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
OPCH Option Care Health Inc

-6.95 (-22.79%)

USD 5.14B
ACHC Acadia Healthcare Company Inc

+0.48 (+0.93%)

USD 4.84B
SGRY Surgery Partners Inc

-0.65 (-2.16%)

USD 4.02B
AMED Amedisys Inc

-0.08 (-0.08%)

USD 3.12B
LFST Lifestance Health Group Inc

-0.01 (-0.15%)

USD 2.67B
ASTH Astrana Health Inc

-0.23 (-0.41%)

USD 2.55B
ADUS Addus HomeCare Corporation

-4.09 (-3.15%)

USD 2.35B
AVAH Aveanna Healthcare Holdings In..

+0.01 (+0.20%)

USD 0.96B
HCSG Healthcare Services Group Inc

+0.03 (+0.27%)

USD 0.76B
CMPS Compass Pathways Plc

-0.03 (-0.48%)

USD 0.44B

ETFs Containing ENSG

OSCV 2.74 % 0.79 %

N/A

N/A
VIOG Vanguard S&P Small-Cap 60.. 1.15 % 0.20 %

-0.23 (0%)

USD 0.97B
RNMC 1.02 % 0.60 %

N/A

N/A
OASC OneAscent Small Cap Core .. 1.01 % 0.00 %

+0.02 (+0%)

USD 0.02B
MWON:XETRA Amundi S&P SmallCap 600 E.. 0.96 % 0.00 %

+0.37 (+0%)

USD 0.22B
USASUS:SW Amundi S&P SmallCap 600 E.. 0.96 % 0.00 %

+0.24 (+0%)

USD 0.22B
CBUSAS:SW Amundi S&P SmallCap 600 E.. 0.85 % 0.00 %

N/A

N/A
ZSML:CA BMO S&P US Small Cap Inde.. 0.61 % 0.00 %

+0.01 (+0%)

N/A
ZSML-F:CA BMO S&P US Small Cap Inde.. 0.61 % 0.00 %

N/A

CAD 5.46M
ZSML-U:CA BMO S&P US Small Cap Inde.. 0.61 % 0.00 %

N/A

N/A
VRTGX Vanguard Russell 2000 Gro.. 0.58 % 0.00 %

-2.10 (0%)

USD 1.19B
RTWO:LSE L&G Russell 2000 US Small.. 0.55 % 0.00 %

+0.70 (+0%)

USD 0.15B
RTWP:LSE Legal & General UCITS ETF.. 0.55 % 0.00 %

+68.00 (+0%)

USD 0.15B
ETLZ:XETRA L&G Russell 2000 US Small.. 0.55 % 0.00 %

+0.13 (+0%)

USD 0.09B
RSSL Global X Funds 0.30 % 0.00 %

-0.11 (0%)

USD 1.45B
ITWO 0.30 % 0.00 %

N/A

N/A
R2SC:LSE SPDR® Russell 2000 US Sm.. 0.29 % 0.00 %

+0.43 (+0%)

USD 3.42B
R2US:LSE SPDR® Russell 2000 US Sm.. 0.29 % 0.00 %

+0.63 (+0%)

USD 3.39B
R2US:PA SSgA SPDR ETFs Europe II .. 0.29 % 0.00 %

+0.19 (+0%)

USD 3.39B
ZPRR:F SSgA SPDR ETFs Europe II .. 0.29 % 0.00 %

+0.04 (+0%)

USD 2.91B
ZPRR:XETRA SPDR® Russell 2000 US Sm.. 0.29 % 0.00 %

+0.20 (+0%)

USD 2.91B
R2US:SW SPDR® Russell 2000 US Sm.. 0.29 % 0.00 %

+0.37 (+0%)

USD 3.43B
XRSG:LSE Xtrackers Russell 2000 UC.. 0.29 % 0.00 %

+204.00 (+0%)

USD 1.45B
XRSU:LSE Xtrackers Russell 2000 UC.. 0.29 % 0.00 %

+2.90 (+0%)

USD 1.45B
XRS2:F Xtrackers (IE) Public Lim.. 0.29 % 0.00 %

-0.80 (0%)

USD 1.19B
XRS2:XETRA Xtrackers Russell 2000 UC.. 0.29 % 0.00 %

+0.90 (+0%)

USD 1.19B
XRS2:SW Xtrackers Russell 2000 UC.. 0.29 % 0.00 %

+1.50 (+0%)

USD 1.45B
VRTIX Vanguard Russell 2000 Ind.. 0.29 % 0.00 %

-0.77 (0%)

USD 10.02B
UWM ProShares Ultra Russell20.. 0.23 % 0.95 %

-0.15 (0%)

USD 0.46B
HDG ProShares Hedge Replicati.. 0.05 % 0.95 %

-0.19 (0%)

USD 0.03B
IWO iShares Russell 2000 Grow.. 0.00 % 0.24 %

-1.46 (0%)

N/A
JSMD Janus Henderson Small/Mid.. 0.00 % 0.50 %

-0.20 (0%)

USD 0.39B
OLD 0.00 % 0.50 %

N/A

N/A
KSCD 0.00 % 0.00 %

N/A

N/A
SLY 0.00 % 0.15 %

N/A

N/A
SLYG SPDR® S&P 600 Small Cap .. 0.00 % 0.15 %

-0.08 (0%)

N/A
URTY ProShares UltraPro Russel.. 0.00 % 0.95 %

-0.24 (0%)

USD 0.45B
VIOO Vanguard S&P Small-Cap 60.. 0.00 % 0.15 %

+0.05 (+0%)

N/A
VTWG Vanguard Russell 2000 Gro.. 0.00 % 0.20 %

-0.70 (0%)

USD 1.01B
VTWO Vanguard Russell 2000 Ind.. 0.00 % 0.15 %

-0.14 (0%)

USD 11.77B
IDP6:LSE iShares S&P SmallCap 600 .. 0.00 % 0.00 %

+0.86 (+0%)

N/A
IUS3:F iShares S&P Small Cap 600.. 0.00 % 0.00 %

N/A

N/A
IUS3:XETRA iShares S&P Small Cap 600.. 0.00 % 0.00 %

+0.32 (+0%)

N/A
SMLE 0.00 % 0.00 %

N/A

N/A
DFAS Dimensional U.S. Small Ca.. 0.00 % 0.00 %

+0.01 (+0%)

USD 8.97B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.30% 77% C+ 67% D+
Dividend Return 0.05% 100% F 1% F
Total Return 6.35% 77% C+ 66% D+
Trailing 12 Months  
Capital Gain 30.66% 89% A- 80% B-
Dividend Return 0.26% 100% F 2% F
Total Return 30.92% 89% A- 79% B-
Trailing 5 Years  
Capital Gain 112.47% 91% A- 85% B
Dividend Return 1.92% 50% F 7% C-
Total Return 114.39% 91% A- 84% B
Average Annual (5 Year Horizon)  
Capital Gain 27.86% 75% C 84% B
Dividend Return 28.19% 75% C 84% B
Total Return 0.33% 50% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 40.97% 54% F 43% F
Risk Adjusted Return 68.81% 96% N/A 89% A-
Market Capitalization 1.10B 100% F 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.30 55% 29%
Price/Book Ratio 4.55 12% 24%
Price / Cash Flow Ratio 17.71 27% 15%
Price/Free Cash Flow Ratio 23.03 22% 10%
Management Effectiveness  
Return on Equity 15.28% 96% 85%
Return on Invested Capital 12.65% 90% 82%
Return on Assets 4.18% 66% 83%
Debt to Equity Ratio 9.75% 69% 71%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector